Intelligent Bio Solutions Drives Global Growth of Fingerprint-Based Drug Testing
Friday, May 16, 2025
Intelligent Bio Solutions Inc, a medical technology company offering rapid, non-invasive testing solutions, has reported recent progress in expanding its global presence. Growth has been driven by new client acquisitions, entry into additional sectors and regions, and increasing use of its solutions across safety-critical industries.
The company’s total number of active accounts has now exceeded 450, with 35 new clients added in the third quarter of its financial year. INBS’s Intelligent Fingerprinting Drug Screening System, which uses fingerprint sweat to detect recent drug use in under ten minutes, continues to gain popularity due to its speed, convenience, and portability. This growth supports the company’s strategy to expand into international markets and strengthen its local presence in areas with high demand.
Recent achievements include:
- Continued uptake across key sectors such as manufacturing, transport, logistics, engineering, and mining.
- Entry into the luxury marine sector in Europe, supporting remote testing on yachts.
- Expansion of testing programmes in regional and remote areas of Australia.
- Adoption within Australia’s waste and recycling sector, including pre-employment and for-cause testing.
- New clients in Australia’s retail industry, including a major e-commerce company.
INBS also plans to introduce a collected testing service to provide more flexible solutions for clients with high testing volumes. To support its global growth, the company is also strengthening its distribution network. Its distributor presence now covers 19 countries, supported by 18 partners offering local expertise and faster market access.
These commercial advances reflect INBS’s ongoing efforts to grow in industries and regions with strong demand for efficient drug testing solutions. With adoption in 24 countries and a growing base of active accounts, the company continues to build momentum ahead of its anticipated launch in the high-value U.S. market.
Source: globenewswire.com
